The Orthofix SpinalStim you’re seeing here ... which seems to have been a problem on older bone stimulators. While I’m disappointed the SpinalStim swallowed its cyanide pill rather than ...

Orthofix Medical Inc. (NASDAQ:OFIX – Get Free Report)’s share price crossed above its two hundred day moving average during trading on Wednesday . The stock has a two hundred day moving average of $17 ...

StockNews.com upgraded shares of Orthofix Medical (NASDAQ:OFIX – Free Report) from a hold rating to a buy rating in a report published on Friday. Other equities analysts have also recently issued ...

report_id=AMR706 The global bone growth stimulators market is highly competitive, with a number of established players as well as new entrants vying for market share. Key players in the market include ...

The analyst is optimistic about Orthofix Medical's unique offerings ... and further penetration in existing accounts, 9% growth in Bone Growth Therapies net sales and 13% growth in BGT Fracture ...